Table 3.
Metabolic biomarkers in plasma and triacylglycerol in liver from mice with different dietary treatments in phases one and two.
| Phase 1 | Control | High-fat |
|---|---|---|
| Plasma | ||
| Glucose (blood), mg/dL | 138.96 ± 4.47b | 160.46 ± 8.73a |
| Insulin, mU/L | 11.71 ± 1.86b | 25.76 ± 2.99a |
| HOMA-IR | 4.12 ± 0.70b | 10.51 ± 19.18a |
| Leptin, ng/mL | 14.88 ± 0.68b | 32.38 ± 5.36a |
| Adiponectin, μg/mL | 6.82 ± 0.18 | 6.61 ± 0.15 |
| Total cholesterol, mg/dL | 92.42 ± 2.46b | 106.19 ± 4.48a |
| HDL cholesterol, mg/dL | 81.28 ± 2.24b | 93.42 ± 3.15a |
| Liver | ||
| Triacylglycerol, mg/g | 18.62 ± 2.66b | 38.11 ± 5.04a |
Values (means ± SEM) in the same row with different letters are significant at p ≤ 0.05 (n = 12 per group). HOMA-IR: Homeostatic model assessment of insulin resistance, HDL: high-density lipoprotein, TRF: time-restricted feeding.